User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
Japan Innovative Medicine Grant
Imagine a future where healthy aging is prioritized, and innovations drive transformative change.
In Japan, the population is aging faster than anywhere else in the world1. With more than one in ten people now aged 80 or older for the first time2, cutting-edge advancements may be more crucial than ever. Therefore, addressing frailty, a condition in older adults that increases their risk of poor health outcomes, is a top priority for research and innovation.3
To help inspire innovations that can prolong healthy life expectancy in Japan and be leveraged globally, Johnson & Johnson launched the Japan Smart Healthy Aging Initiative (SHAI) aims to improve the lives of the aging population by working with other partners from hospital institutions, academia, government, business, and the healthcare industry, expanding both the breadth and depth of our offerings, and delivering a truly holistic approach to healthy aging. The platform serves to test, prove, and build holistic, data-driven smart healthy aging solutions.
In support of this initiative, Johnson & Johnson is proud to launch the Japan Smart Healthy Aging QuickFire Challenge 2024. Japan-based innovators and those from across the globe working on Japan-focused innovations* are invited to submit promising science or technologies that aim to potentially increase healthy life expectancy – to help people live longer, happier lives. Innovations should focus on driving scientific progress within Japan and serving the needs of the Japanese population.
The innovator(s) with the best potential solutions will have the chance to receive grant funding from a total pool of $200,000, virtual access to the Johnson & Johnson Innovation Asia Pacific ecosystem for one year, and mentorship from experts across Johnson & Johnson.*
We are searching for innovators who share a vision where aging does not limit an individual’s ability to live a full and vibrant life.
Japan-based innovators and those from across the globe working on Japan-focused innovations* are invited to submit promising science or technologies that aim to potentially increase healthy life expectancy. Innovations should focus on driving scientific progress within Japan and serving the needs of the Japanese population. We are specifically interested in advancements in:
Innovative Medicine
- Oncology
- Breakthrough therapies and transformational approaches for bladder, lung, prostate, and hematological cancers
- Technologies that improve prognostic forecast
- Approaches for engaging with aging populations for recruitment to clinical trials
- Data Science & Digital Health Technologies
- AI/ ML technologies to improve and accelerate therapeutics discovery
- AI/ML-assisted precision medicine & digital health approaches to advance patient identification and enhance clinical development
- Holistic evidence generation technologies to augment, contextualize randomized controlled trials to inform decision-making
MedTech
- Vision
- Cataract Surgery and IOL Technologies:
- Extending range of vision, improved quality of vision and optical adjustability
- Novel presbyopia correction technologies/treatments inc. accommodating IOL’s
- Streamlining cataract surgical workflow for improved efficiency and patient outcomes
- Contact Lens Technologies:
- Novel presbyopia solutions for improved range of vision
- Presbyopia patient screening and fitting methods to improve eye care practitioner (ECP) fitting success
- Improve patient experience and vision outcomes inc. with multifocal lenses
- Light management approaches to improve vision and ocular health
- Ocular Drug Delivery Technologies for anterior and posterior segment diseases and ocular health
- Cataract Surgery and IOL Technologies:
- Robotics and Digital: Enabling technologies such as AI, AR, analytics, navigation, robotics and tech-guided, smart sensors, and implants that aim to support advanced visualization and facilitate planning and decision-making in the treatment of complex diseases.
- BioMedTech: Development of biomaterials and biologics to enable early intervention and promote healing.
Awards
The innovator(s) with the best potential solutions will have the chance to receive grant funding from a total pool of $200,000, virtual access to the Johnson & Johnson Innovation Asia Pacific ecosystem for one year, and mentorship from experts across Johnson & Johnson.
Specialties
Eligibility Requirements
Potential solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- Potential impact and relevance to aging populations
- Uniqueness of potential solution & level of competition in current market
- Quality & feasibility of technology
- Team credibility & capabilities
- Potential solution is validated through data and/or proof of concept
- Innovation is Japan-focused. The submitted innovation must be centered on advancing science within the Japan region and benefitting the Japanese population. Applicants located outside of Japan are eligible to participate, provided they can fulfill one or more of the following criteria:
- Applicant company has physical presence in Japan (e.g., at least one Founder/Co-Founder(s)/Founding Member(s)/C-Suite Executive located in Japan)
- Applicant can clearly demonstrate that innovation was inspired by and/or insights gained in Japan
- Applicant has existing or planned collaborations in Japan
- Ability to take innovation to market in 2 to 3 years
Eligible Countries:
Sponsor Details
Sponsor Institute/Organizations: Johnson & Johnson
Address: 5-2, Nishi-Kanda 3-chome Chiyoda-ku, Tokyo 101-0065 Japan
Legal & Affiliation Disclaimer
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Grant
Final Deadline:
Jan 31, 2025
Funding Amount:
$200,000
Host Details
Affiliation: Johnson & Johnson
Address: 5-2, Nishi-Kanda 3-chome Chiyoda-ku, Tokyo 101-0065 Japan
Website URL: https://jnjinnovation.com/innovation-challenges/Japan-Smart-Healthy-Aging-QuickFire-Challenge-2024
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts